Authors: King, W Proffitt, J Morrison, L Piper, J Lane, D Seelig, S

Citation: W. King et al., The role of fluorescence in situ hybridization technologies in molecular diagnostics and disease management, MOL DIAGN, 5(4), 2000, pp. 309-319

Authors: Remstein, ED Kurtin, PJ Buno, I Bailey, RJ Proffitt, J Wyatt, WA Hanson, CA Dewald, GW

Citation: Ed. Remstein et al., Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma, BR J HAEM, 110(4), 2000, pp. 856-862

Authors: Proffitt, J Fenton, J Pratt, G Yates, Z Morgan, G

Citation: J. Proffitt et al., Isolation and characterisation of recombination events involving immunoglobulin heavy chain switch regions in multiple myeloma using long distance vectorette PCR (LDV-PCR), LEUKEMIA, 13(7), 1999, pp. 1100-1107

Authors: Dellas, A Torhorst, J Jiang, F Proffitt, J Schultheiss, E Holzgreve, W Sauter, G Mihatsch, MJ Moch, H

Citation: A. Dellas et al., Prognostic value of genomic alterations in invasive cervical squamous cellcarcinoma of clinical stage IB detected by comparative genomic hybridization, CANCER RES, 59(14), 1999, pp. 3475-3479

Authors: Proffitt, J Bastin, DA Lehrbach, PR

Citation: J. Proffitt et al., Sequence analysis of Australian infectious bursal disease viruses, AUST VET J, 77(3), 1999, pp. 186-188